Editorial
Published on 06 Jun 2025
Editorial: Health-related quality of life among Hodgkin lymphoma survivors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1625160
- 1,228 views
Type at least 3 characters
2,001 articles
articles
Case Report
Published on 03 Jun 2025
Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1585088
- 2,015 views
Case Report
Published on 03 Jun 2025
Case Report: Epididymal NK/T-cell lymphoma and adrenal diffuse large B-cell lymphoma are misdiagnosed as tuberculosis: two case reports and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1529049
- 2,088 views
Case Report
Published on 27 May 2025
Unilateral sudden hearing loss as the first presenting symptom of chronic myeloid leukemia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1579765
- 2,508 views
- 1 citation
Original Research
Published on 23 May 2025
CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1566938
- 3,385 views
- 3 citations
Case Report
Published on 21 May 2025
Novel compound heterozygous PIEZO1 variants in dehydrated hereditary stomatocytosis initially suspected as myelodysplastic syndromes: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1574518
- 1,892 views
Original Research
Published on 21 May 2025
Clinical characteristics of diffuse large B-cell lymphoma complicated with multiple primary malignant neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1592517
- 1,413 views
Original Research
Published on 15 May 2025
Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1569370
- 1,886 views
Original Research
Published on 15 May 2025
Divergent gene expression of PTGS1 and PTGS2 along the disease course of chronic myeloid leukaemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1556956
- 1,948 views
Original Research
Published on 14 May 2025
Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586839
- 3,073 views
- 1 citation
Original Research
Published on 14 May 2025
Hematological cancer patients’ social support, coping strategies, anxiety, depression and posttraumatic growth: a structural equation model
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1540973
- 2,526 views
- 2 citations
Case Report
Published on 12 May 2025
Case Report: Sclerosing variant of extramedullary hematopoietic tumor primary arising in kidney, unexpected clinical and pathological presentation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1573784
- 1,468 views
Original Research
Published on 12 May 2025
Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1587185
- 2,395 views
Original Research
Published on 09 May 2025
Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1547138
- 3,764 views
Original Research
Published on 08 May 2025
Impact of secondary hematologic malignancies on prognosis of Hodgkin’s lymphoma survivors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1566063
- 1,767 views
Original Research
Published on 08 May 2025
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1569707
- 2,157 views
Review
Published on 08 May 2025
The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1546813
- 4,887 views
- 5 citations
Correction
Published on 06 May 2025
Corrigendum: Lipid have a direct effect on multiple myeloma: a Mendelian randomization study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1603501
- 1,265 views
Case Report
Published on 02 May 2025
Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1529640
- 1,784 views
Review
Published on 01 May 2025
Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1546641
- 4,163 views
- 2 citations
Case Report
Published on 01 May 2025
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a patient with pre-existing essential thrombocythemia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1573893
- 2,315 views
Review
Published on 29 Apr 2025
A potential prognostic marker for hematologic neoplasms: CD58
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586842
- 2,809 views
- 1 citation
Original Research
Published on 28 Apr 2025
TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B–cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1550207
- 3,619 views
- 2 citations
Original Research
Published on 24 Apr 2025
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1563990
- 2,573 views
- 1 citation